| 000 | 00960 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250518063306.0 | ||
| 264 | 0 | _c20200604 | |
| 008 | 202006s 0 0 eng d | ||
| 022 | _a2168-6114 | ||
| 024 | 7 |
_a10.1001/jamainternmed.2019.3626 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aThompson, Ian M | |
| 245 | 0 | 0 |
_a5α-Reductase Inhibitor Use in Patients With Prostate Cancer. _h[electronic resource] |
| 260 |
_bJAMA internal medicine _c10 2019 |
||
| 300 |
_a1440 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _a5-alpha Reductase Inhibitors |
| 650 | 0 | 4 | _aFinasteride |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aOxidoreductases |
| 650 | 0 | 4 | _aProstatic Neoplasms |
| 700 | 1 | _aTangen, Catherine M | |
| 700 | 1 | _aKramer, Barnett | |
| 773 | 0 |
_tJAMA internal medicine _gvol. 179 _gno. 10 _gp. 1440 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/jamainternmed.2019.3626 _zAvailable from publisher's website |
| 999 |
_c30178886 _d30178886 |
||